WASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to supportWASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support

DIA Launches ASCENT Platform and LIFT Biotech & Startup Program to Accelerate Emerging Innovation

WASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support early-stage biotechnology drug development innovation, along with its inaugural initiative, the LIFT (Linking Innovation, Funding, and Translation) Series. Together, ASCENT and LIFT create a structured, multi-stage pathway to educate, prepare, and connect emerging biotech and startup companies with investors, regulators, pharma leaders, and development organizations across the full product lifecycle.

DIA announces ASCENT and LIFT Series to advance early-stage biotech innovation and collaboration.

Built to address persistent barriers facing early-stage innovators, such as limited investor access, fragmented access to expertise, and unclear regulatory pathways, and steep execution gaps, ASCENT extends DIA’s role as a trusted, multi-stakeholder convener to the earliest phases of innovation. Through curated education, mentorship, regulatory insight, and global exposure, the platform aims to strengthen the life sciences innovation pipeline worldwide.

The DIA LIFT Series unfolds across three integrated program offerings in 2026. Phase I launches with a Virtual Masterclass Series beginning in February 2026, featuring expert-led sessions with case studies focused on fund-raising, drug development including the role of AI, regulatory strategy, clinical development and financial modeling.

Phase II brings LIFT Series to DIA Europe 2026 in Rotterdam, Netherlands (March 24–26, 2026), with dedicated LIFT Programming for Biotech & Startups embedded within a globally attended meeting of more than 2,500 professionals. Programming includes expert coaching, live pitch competitions, regulator and investor roundtables, and curated networking opportunities.

Phase III culminates at the DIA 2026 Global Annual Meeting  in Philadelphia, Pennsylvania (June 14–18, 2026), featuring expanded LIFT Series Biotech & Startup programming, a Startup Row, and two targeted pitch events focused on drug and therapy development and techbio innovation, all within a 4,000+ attendee global forum.

“Our mission has always been to convene the global life sciences community to improve health worldwide,” said Marwan Fathallah, CEO of DIA. “With ASCENT and the LIFT Series Program, we are extending that mission earlier in the innovation journey providing emerging companies with the insight, connections, and visibility needed to advance promising science and strengthen the entire ecosystem.”

Registration for the LIFT Virtual Masterclass Series is now open. Details for Annual Meeting registrations and pitch competitions is available with pitch applications opening soon.

To learn more, visit: https://connect.diaglobal.org/dia-ascent-1

About DIA

DIA is a leading global non-profit life science membership association that drives collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.

Learn more at DIAglobal.org.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dia-launches-ascent-platform-and-lift-biotech–startup-program-to-accelerate-emerging-innovation-302665447.html

SOURCE Drug Information Association

Market Opportunity
Startup Logo
Startup Price(STARTUP)
$0.0001586
$0.0001586$0.0001586
-1.12%
USD
Startup (STARTUP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip

Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip

The post Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip appeared on BitcoinEthereumNews.com. Gold is strutting its way into record territory, smashing through $3,700 an ounce Wednesday morning, as Sprott Asset Management strategist Paul Wong says the yellow metal may finally snatch the dollar’s most coveted role: store of value. Wong Warns: Fiscal Dominance Puts U.S. Dollar on Notice, Gold on Top Gold prices eased slightly to $3,678.9 […] Source: https://news.bitcoin.com/gold-hits-3700-as-sprotts-wong-says-dollars-store-of-value-crown-may-slip/
Share
BitcoinEthereumNews2025/09/18 00:33
ZKP’s Proof Generation Edge: The $100M Privacy Layer DOGE and XRP Don’t Have

ZKP’s Proof Generation Edge: The $100M Privacy Layer DOGE and XRP Don’t Have

Dogecoin, XRP, and ZKP represent three very different bets for the next cycle,  and the market is already separating speculation from structure. The Dogecoin price
Share
Blockonomi2026/01/22 01:00
Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be

Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be

The post Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be appeared on BitcoinEthereumNews.com. Jordan Love and the Green Bay Packers are off to a 2-0 start. Getty Images The Green Bay Packers are, once again, one of the NFL’s better teams. The Cleveland Browns are, once again, one of the league’s doormats. It’s why unbeaten Green Bay (2-0) is a 8-point favorite at winless Cleveland (0-2) Sunday according to betmgm.com. The money line is also Green Bay -500. Most expect this to be a Packers’ rout, and it very well could be. But Green Bay knows taking anyone in this league for granted can prove costly. “I think if you look at their roster, the paper, who they have on that team, what they can do, they got a lot of talent and things can turn around quickly for them,” Packers safety Xavier McKinney said. “We just got to kind of keep that in mind and know we not just walking into something and they just going to lay down. That’s not what they going to do.” The Browns certainly haven’t laid down on defense. Far from. Cleveland is allowing an NFL-best 191.5 yards per game. The Browns gave up 141 yards to Cincinnati in Week 1, including just seven in the second half, but still lost, 17-16. Cleveland has given up an NFL-best 45.5 rushing yards per game and just 2.1 rushing yards per attempt. “The biggest thing is our defensive line is much, much improved over last year and I think we’ve got back to our personality,” defensive coordinator Jim Schwartz said recently. “When we play our best, our D-line leads us there as our engine.” The Browns rank third in the league in passing defense, allowing just 146.0 yards per game. Cleveland has also gone 30 straight games without allowing a 300-yard passer, the longest active streak in the NFL.…
Share
BitcoinEthereumNews2025/09/18 00:41